Speaker Profile

___	__
	Biography Dr. Sukhbir (Sony) Singh is Professor and Chair of the Department of Obstetrics and Gynecology at the University of Ottawa and Head of the Department of Obstetrics, Gynecology and Newborn Care at The Ottawa Hospital. He is an Associate Scientist and the Dr. Elaine Jolly Research Chair in Gynecologic Surgery at The Ottawa Hospital Research Institute. Upon completion of his medical training at the University of Western Ontario (MD 2000, FRCSC 2005), he completed fellowships in minimally invasive gynecologic surgery at the University of Toronto (2005-2006) and the University of Sydney, Australia (2006-2007). His clinical expertise focuses on the surgical management of deep endometriosis, chronic pelvic pain and uterine fibroids. His leadership roles include Fellowship Co-Director of the Ottawa AAGL Fellowship in Minimally Invasive Gynecology. He is the co-founder and past Executive Director of the Canadian Society for the Advancement of Gynecologic Excellence (CanSAGE) and past Board Member for the AAGL. Dr. Singh is a volunteer member of EndoAct, a national advocacy group with the aim to improve access and care for those with endometriosis. Dr. Singh leads the Ottawa Minimally Invasive Gynecology Research Group which focuses on the diagnosis, management and surgical approach to endometriosis and uterine fibroids. He has given over 400 presentations worldwide, delivered 50 formal courses and has over 150 publications to date. Disclosure I have a relationship with a for-profit and/or a not-for-profit organization to disclose: - Direct financial payments including receipt of honoraria: Myovant (CME Speaker), Bayer (CME Speaker), Abbvie (CME Speaker), Pfizer (CME Speaker) - Membership on advisory boards or speakers’ bureaus: Pfizer - Funded grants or clinical trials: Bayer (Menopause Trial) I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).

Biography
Dr. Sukhbir (Sony) Singh is Professor and Chair of the Department of Obstetrics and Gynecology at the University of Ottawa and Head of the Department of Obstetrics, Gynecology and Newborn Care at The Ottawa Hospital. He is an Associate Scientist and the Dr. Elaine Jolly Research Chair in Gynecologic Surgery at The Ottawa Hospital Research Institute. Upon completion of his medical training at the University of Western Ontario (MD 2000, FRCSC 2005), he completed fellowships in minimally invasive gynecologic surgery at the University of Toronto (2005-2006) and the University of Sydney, Australia (2006-2007). His clinical expertise focuses on the surgical management of deep endometriosis, chronic pelvic pain and uterine fibroids. His leadership roles include Fellowship Co-Director of the Ottawa AAGL Fellowship in Minimally Invasive Gynecology. He is the co-founder and past Executive Director of the Canadian Society for the Advancement of Gynecologic Excellence (CanSAGE) and past Board Member for the AAGL. Dr. Singh is a volunteer member of EndoAct, a national advocacy group with the aim to improve access and care for those with endometriosis. Dr. Singh leads the Ottawa Minimally Invasive Gynecology Research Group which focuses on the diagnosis, management and surgical approach to endometriosis and uterine fibroids. He has given over 400 presentations worldwide, delivered 50 formal courses and has over 150 publications to date.
Disclosure
I have a relationship with a for-profit and/or a not-for-profit organization to disclose: - Direct financial payments including receipt of honoraria: Myovant (CME Speaker), Bayer (CME Speaker), Abbvie (CME Speaker), Pfizer (CME Speaker) - Membership on advisory boards or speakers’ bureaus: Pfizer - Funded grants or clinical trials: Bayer (Menopause Trial) I do not intend to make therapeutic recommendations for medications that have not received regulatory approval (i.e. “off-label” use of medication).